Open-label, Single-arm, Multi-center, Pharmacokinetic, Safety and Tolerability Study of Levetiracetam Intravenous Infusion in Children (1 Month- 4 Years Old) With Epilepsy
Phase of Trial: Phase II
Latest Information Update: 17 Jul 2015
At a glance
- Drugs Levetiracetam (Primary)
- Indications Epilepsy
- Focus Adverse reactions
- Sponsors UCB Pharma Inc
- 24 Mar 2012 Planned number of patients changed from 18 to 22 as reported by European Clinical Trials Database record.
- 24 Mar 2012 This trial has been completed in Belgium and Germany; and recruiting in France as reported by European Clinical Trials Database record.
- 07 Apr 2010 Actual patient number (20) added as reported by ClinicalTrials.gov.